Federation des caisses Desjardins du Quebec’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,050
| Closed | -$392 | – | 2918 |
|
|
2025
Q3 | $392 | Sell |
2,050
-2,000
| -49% | -$2.4K | ﹤0.01% | 2747 |
|
|
2025
Q2 | $6.88K | Hold |
4,050
| – | – | ﹤0.01% | 2173 |
|
|
2025
Q1 | $6.4K | Hold |
4,050
| – | – | ﹤0.01% | 2102 |
|
|
2024
Q4 | $7.25K | Hold |
4,050
| – | – | ﹤0.01% | 1983 |
|
|
2024
Q3 | $24.5K | Buy |
4,050
+2,000
| +98% | +$11K | ﹤0.01% | 1597 |
|
|
2024
Q2 | $10.8K | Buy |
2,050
+2,000
| +4,000% | +$12.7K | ﹤0.01% | 1796 |
|
|
2024
Q1 | $425 | Hold |
50
| – | – | ﹤0.01% | 2253 |
|
|
2023
Q4 | $330 | Hold |
50
| – | – | ﹤0.01% | 2231 |
|
|
2023
Q3 | $155 | Hold |
50
| – | – | ﹤0.01% | 2287 |
|
|
2023
Q2 | $135 | Hold |
50
| – | – | ﹤0.01% | 2264 |
|
|
2023
Q1 | $149 | Hold |
50
| – | – | ﹤0.01% | 2266 |
|
|
2022
Q4 | $126 | Hold |
50
| – | – | ﹤0.01% | 2416 |
|
|
2022
Q3 | $91 | Hold |
50
| – | – | ﹤0.01% | 2469 |
|
|
2022
Q2 | $158 | Buy |
+50
| New | +$279 | ﹤0.01% | 2491 |
|
Federation des caisses Desjardins du Quebec's EPIX Position: Q4 2025 in Review
Federation des caisses Desjardins du Quebec sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 2,050 shares — an estimated $392 sold.
Federation des caisses Desjardins du Quebec first reported a position in EPIX in Q2 2022 and held it in 14 quarters. The position peaked at $24.5K in Q3 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- Federation des caisses Desjardins du Quebec reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 2,050 ESSA Pharma shares in Q4 2025, an estimated $392.
- Federation des caisses Desjardins du Quebec first reported a position in ESSA Pharma in Q2 2022 and held it in 14 quarters.
- Federation des caisses Desjardins du Quebec's ESSA Pharma position peaked at $24.5K in Q3 2024.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2025, filed 12 Feb 2026.